Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

Early MOtion Total Ankle Artroplasty

NCT06525545 · tracked via the Priya Life Science Italy tracker
Phase
Not applicable
Started
2023-10-31
Last updated
2024-08-02

Condition(s) studied

Ankle OsteoarthritisAnkle - Recurrent DislocationCartilage DiseaseAnkle Arthropathy

Investigational drug(s) / intervention(s)

early mobilizzation of the ankle

early mobilizzation of the ankle: perform flexion-extension exercises of the operated ankle

Study summary

Evaluate the clinical and radiographic results of patients undergoing total ankle arthroplasty and treated in the post-operative period in a randomized manner with early mobilization of the ankle joint or with cast immobilization for 3 weeks

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * Adult patients (aged between 18 and 80). * Male or female patients; * Signature of the informed consent for participation in the study; * Patients prepared and motivated to comply with the scheduled follow-up visits and the completion of the study questionnaires Exclusion Criteria: * main diagnosis other than osteoarthritis, history of ankle infection * need to carry out surgical interventions associated with total prosthesis ankle (e.g., calcaneal osteotomy, knee lowering osteotomy). first metatarsal bone, supramalleolar osteotomy, etc.) * intraoperative complications (for example a malleolar fracture) which require a different post-operative protocol * peripheral vascular disease * marked osteoporosis of the ankle and foot * osteonecrosis of the talus * neurological disorders affecting the lower limb inability to understand study information or respond to questionnaires due to cognitive or linguistic deficits * patients who are pregnant or breastfeeding

Primary outcome measure(s)

  • AOFAS score — 3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery
    The American Orthopedic Foot and Ankle Society Score is a semi-objective rating scale that evaluates ankle pain, motion and alignment and ranges from 0 to 100 points. 0 worst possible score, 100 best possible score
  • MOXFQ — 3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery
    The MOXFQ is a 16-item instrument answered on a five-point Likert scale (each item is scored from 0 to 4, with 4 denoting 'most severe'). Scores for each item are summed to form three separate subscales representing underlying domains: walking/standing problems (seven items), foot pain (five items), and issues related to social interaction (four items). Raw scale scores are then each converted to a metric from 0 to 100, where 100 denotes the most severe.
  • SF-36 Questionnaire o Short Form-36 Health Survey — 3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery
    The 36-Item Short Form Health Survey (SF-36) is a popular questionnaire for measuring the self- erception of quality of life in a given population of interest. Processing the answers of a participant comprises the calculation of 10 scores corresponding to 8 scales measuring several aspects of perceived health and 2 summary components (physical and mental)The scores range from 0 point (best) to 100 (worst).
  • VAS — 3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery
    A Visual Analogue Scale (VAS) is a pain rating scales and ranges from 0 to 10 points
  • STTA - Sagittal TibioTalar Angle — 3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery
    In a lateral weight-bearing radiograph, the saggittal Tibio Talar Angle is the angke between the rantomica axis of the tibia and the he longitudinal axis of the talus, this is determined by drawing a line connecting the midpoints of a line bisecting the talar neck and another line bisecting the talar body
  • Hindfoot Alignment - Saltzman view mesurament — 3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery
    On the saltzman radiologial view is calculated thedistance between the axis of the tibia shaft and the contact point of the heel. Normal values -3 ± 7 mm
  • Lateral distal tibial angle - LDTA — 3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery
    Lateral distal tibia angle (LDTA) is measured between the mid-diaphyseal line of the tibia and the line parallel to the distal tibial plafond. The lateral distal tibial angle has a norm of 89 degrees ± 3 degrees
  • Anterior distal tibial angle - ADTA — 3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery
    The ADTA is formed by the mechanical axis of the tibia and the joint orientation line of the ankle in the sagittal plane and measures 80° ± 3° in the normal lower extremity
  • Tibio-Talar Angle - TTA — 3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery
    The tibiotalar angle is between the anatomic axis of the tibia and the superior articular surface of the talar dome. The mean and standard deviation are: 88.7° ± 5.1°
  • Center of Rotation of Angulation CORA — 3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery
    The CORA is the intersection of the mid-diaphyseal line and the line starting from the middle of the joint and perpendicular to the abnormal ADTA or LDTA. The CORA can be located at the joint line level (usually due to anatomical joint line malalignment or to ankle degeneration) or proximally (usually due to tibial deformities/fractures).
  • Gamma Angle — 3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery
    Gamma angle (γ) is formed by intersection of line drawn through long axis of talar component with line drawn from posterior talar component through middle of talar neck.
  • T-T ratio (Tibio-talar Ratio) — 3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery
    Tibiotalar ratio (TT ratio). A talar reference line is drawn parallel to the floor from the posterior talar point (defined as the intersection between the posterosuperior calcaneal cortex and the posterior subtalar articular surface) to the anterior talar point (vertical projection of the most anterior point of the talus onto the talar reference line). Next, the distal tibial axis is the line drawn between the midpoint of the distal tibial shaft measured 5 and 10 cm above the ankle. This divides the talar reference line into anterior and posterior segments. The TT ratio is the ratio of the length of the posterior segment of the talus (AC) to the longitudinal talar length (AB), expressed as a percentage. Normal value, 27% to 42%

Trial sites (1)

FacilityCityRegionStatus
Istituto Ortopedico Rizzoli Bologna Italia Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06525545 on ClinicalTrials.gov ↗ ← All trials in Italy